New Medicare Reimbursement Code For Orthovisc For Patients With Osteoarthritis, USA

... DePuy Mitek, Inc., a Johnson & Johnson company, today announced that the Centers for Medicare & Medicaid Services (CMS) has assigned a new reimbursement HCPCS ("J") Code to ORTHOVISC®, an ultra pure hyaluronan injectable used to improve mobility and treat knee pain caused by osteoarthritis.The HCPCS J Code, J7319, will take effect in January 2007 and will cover all hyaluronic acids. [click link for full article] ...